February 18, 2022 by Chain Drug Review
chief executive officer B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) issued the following statement on behalf of NCPA CEO B. Douglas Hoey in reaction to a deadlock vote by the FTC on whether to investigate PBMs, effectively killing the proposal at least for now: “Two members of the FTC just let the worst actors in the market off the
June 4, 2021 by Chain Drug Review
chief executive officer B. Douglas Hoey, National Community Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The Federal Trade Commission recently released a report about the effects of pharmacy benefit manager “rebate wall” contracting practices on competition in prescription drug markets. Among other observations, the report notes that rebate walls “may give payers strong incentives to block patient access to lower-priced medicines, whereas absent rebates a lower-priced equally effective product
March 24, 2021 by Chain Drug Review
chief executive officer B. Douglas Hoey, The National Community Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association has released a 2020 COVID-19 special report detailing the organization’s extensive work over the last year to help independent pharmacists fight the coronavirus pandemic and adjust to the changes the public health emergency had on their small businesses. NCPA also released its 2020 NCPA Advocacy Annual Report,
October 22, 2020 by Chain Drug Review
ational Community Pharmacists Association, chief executive officer B. Douglas Hoey
Pharmacy

ALEXANDRIA, Va. — In a recent letter to state attorneys general, the National Community Pharmacists Association warned that a partnership between two massive pharmacy benefit managers will squash local pharmacies and ultimately limit consumer choices. “These two companies operating separately already exert tremendous downward pressure on independent pharmacies. By joining forces, they can put many
October 19, 2020 by Chain Drug Review
Amina Abubakar, chief executive officer B. Douglas Hoey, NCPA, Rx Clinic Pharmacy
Pharmacy

ALEXANDRIA, Va. — Amina Abubakar, owner of Rx Clinic Pharmacy in Charlotte, N.C., has been named the National Community Pharmacists Association’s 2020 Willard B. Simmons Independent Pharmacist of the Year. The award is sponsored by Upsher-Smith Laboratories, LLC. Abubakar received the award as part of NCPA’s Annual Convention, which was held virtually Oct. 18-19, 2020.
October 19, 2020 by Chain Drug Review
Cardinal Health, chief executive officer B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The 2020 NCPA Digest, sponsored by Cardinal Health, was released today as part of the National Community Pharmacists Association’s Annual Convention. The NCPA Digest, which provides an annual overview of independent community pharmacy, found that the industry in 2019 represented 35 percent of all retail pharmacies in the United States and a $73.7 billion marketplace.
September 28, 2020 by Jeffrey Woldt
chief executive officer B. Douglas Hoey, DIR, NCPA, Video Forum
Featured Articles, Leading Headlines, Pharmacy, Videos

In this week’s Video Forum, Doug Hoey, chief executive officer of the National Community Pharmacists Association, talks about some of the issues confronting independent drug stores and the larger pharmacy sector. Scope of practice, DIR fees, and Rutledge vs. PCMA, which will be taken up by the Supreme Court in October, are among the subjects
August 28, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — Registration opens Friday, Aug. 28, 2020, for the National Community Pharmacists Association 2020 Annual Convention, coming to you this year wherever you are. “This will be the most convenient, most affordable NCPA Convention we’ve ever had,” said NCPA CEO B. Douglas Hoey, pharmacist, MBA. “If you were unable to attend in previous years because of the cost,
June 4, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, The National Community Pharmacists Association, The Paycheck Protection Program Flexibility Ac
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association cheered Senate passage of a measure allowing small businesses that receive emergency loans under the Paycheck Protection Program up to two years to qualify for forgiveness. “This is an important victory for local pharmacies that are trying to position their businesses as part of the economic recovery
May 22, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19 testing, Gov. Andrew Cuomo, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — During his daily press conference on the coronavirus pandemic, New York Governor Andrew Cuomo announced a COVID-19 testing pilot program that will involve independent pharmacies and have the goal of conducting 7,000 tests per week. The pilot is coordinating with the Pharmacists Society of the State of New York and with the state’s network of CPESN clinically integrated pharmacies. The National Community Pharmacists Association,
April 27, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — As the coronavirus pandemic continues straining small business independent community pharmacies, 115 members of the U.S. House of Representatives are supporting a bipartisan push to include language permanently prohibiting pharmacy direct and indirect remuneration clawbacks by pharmacy benefit managers in future coronavirus relief packages. The letter was led by Reps. Buddy Carter
April 8, 2020 by Chain Drug Review
chief executive officer B. Douglas Hoey, COVID-19, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — In a new video, National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA, cheers community pharmacists on the front line of the fight against the coronavirus pandemic. Hoey applauds the pharmacists for being a safety net for their communities and thanks them for their hard work. “Community pharmacists are retooling their practices to
October 16, 2019 by Chain Drug Review
chief executive officer B. Douglas Hoey, National Community Pharmacists Association (NCPA)
Leading Headlines, Pharmacy

ALEXANDRIA, Va. – A substantial majority of independent pharmacies say they may close their doors in the next two years, and the main culprits are multi-billion-dollar corporate middlemen who are shaking them down for fees on medicines long after the point of sale, according to a new survey by the National Community Pharmacists Association (NCPA), released